We are delighted to announce that In-San Kim, the co-founder of SHIFTBIO INC and a fellow at the KIST (Korea Institute of Science and Technology), was invited as a speaker to the ANZSEV 2023 (Australia and New Zealand Society for Extracellular Vesicles) Conference.
The ANZSEV 2023, held in Adelaide, Australia, from November 7th to 10th, facilitated a vibrant global network to enhance understanding of EVs (Extracellular Vesicles). Dr. Kim introduced SHIFTBIO INC's groundbreaking EV-based platform technology during the conference, which aims to overcome the limitations of traditional treatment options and indicate the potential for novel therapeutic strategies.
Stay tuned for the advancements and exciting new journeys of SHIFTBIO INC!
We are delighted to announce that In-San Kim, the co-founder of SHIFTBIO INC and a fellow at the KIST (Korea Institute of Science and Technology), was invited as a speaker to the ANZSEV 2023 (Australia and New Zealand Society for Extracellular Vesicles) Conference.
The ANZSEV 2023, held in Adelaide, Australia, from November 7th to 10th, facilitated a vibrant global network to enhance understanding of EVs (Extracellular Vesicles). Dr. Kim introduced SHIFTBIO INC's groundbreaking EV-based platform technology during the conference, which aims to overcome the limitations of traditional treatment options and indicate the potential for novel therapeutic strategies.
Stay tuned for the advancements and exciting new journeys of SHIFTBIO INC!